AI-generated summary
The authors review photobiomodulation in cardiovascular disease and describe pharmacological strategies that may enhance its effects, including combination with antioxidants and coenzyme Q10. They report these combinations may reduce inflammation, increase ATP production and improve vasodilation. The authors state that further investigation is needed to validate these approaches and explore their clinical impact.
- Who or what was studied
- Patients with cardiovascular diseases, including hypertensive patients resistant to conventional treatments
- Limits stated in the abstract
- The abstract states that further investigation is needed to validate these approaches and explore their clinical impact.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Reactive oxygen species, Oxidative stress, Adenosine triphosphate, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.